Biomarkers in Disease Diagnosis and Treatment

作者: Ralf Hoffmann

DOI: 10.1007/1-4020-4384-8_17

关键词:

摘要:

参考文章(70)
Richard A Frank, Douglas Galasko, Harald Hampel, John Hardy, Mony J de Leon, Pankaj D Mehta, Joseph Rogers, Eric Siemers, John Q Trojanowski, Biological markers for therapeutic trials in Alzheimer’s disease: Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer’s disease Neurobiology of Aging. ,vol. 24, pp. 521- 536 ,(2003) , 10.1016/S0197-4580(03)00002-2
Bichsel Ve, Petricoin Ef rd, Liotta La, Cancer proteomics: from biomarker discovery to signal pathway profiling. Cancer Journal. ,vol. 7, pp. 69- 78 ,(2001)
Ismail Kola, John Landis, Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery. ,vol. 3, pp. 711- 716 ,(2004) , 10.1038/NRD1470
Petersen Rc, Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia. ,vol. 15, pp. 93- 101 ,(2000)
Phulwinder K. Grover, Martin I. Resnick, Analysis of prostatic fluid: Evidence for the presence of a prospective marker for prostatic cancer The Prostate. ,vol. 26, pp. 12- 18 ,(1995) , 10.1002/PROS.2990260104
E. C. Gunther, D. J. Stone, R. W. Gerwien, P. Bento, M. P. Heyes, Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 9608- 9613 ,(2003) , 10.1073/PNAS.1632587100
Odile Carrette, Isabelle Demalte, Alexander Scherl, Oezkarn Yalkinoglu, Garry Corthals, Pierre Burkhard, Denis F. Hochstrasser, Jean-Charles Sanchez, A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics. ,vol. 3, pp. 1486- 1494 ,(2003) , 10.1002/PMIC.200300470